Elamipretid Improves Fitness In Barth Syndrome, Analysis Finds
Elamipretid (MTP-131) improves the fitness of people with Barth syndrome, compared to the natural course of the disease, according to a new comparison using data from the TAZPOWER phase 2/3 clinical trial.
Stealth BioTherapeutics, the…